77 related articles for article (PubMed ID: 227232)
1. Effect of nicomol on HDL cholesterol level.
Watanabe M; Taketa K; Nagashima H; Yamamoto Y
Acta Med Okayama; 1979 Aug; 33(4):323-6. PubMed ID: 227232
[TBL] [Abstract][Full Text] [Related]
2. [Cholesterol bound to high density lipoproteins: critical review of the methods of analysis and personal data].
Orso Giacone G
Ann Osp Maria Vittoria Torino; 1982; 24(7-12):286-306. PubMed ID: 7137764
[TBL] [Abstract][Full Text] [Related]
3. [HDL cholesterol in patients with peripheral arteriosclerotic occlusive disease].
Müller G; Senger U; Lux E
Z Gesamte Inn Med; 1983 May; 38(10):280-2. PubMed ID: 6613191
[TBL] [Abstract][Full Text] [Related]
4. Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia.
Oida K; Nakai T; Tamai T; Kutsumi Y; Kobayashi T; Hayashi T; Yamada S; Takeda R
Artery; 1982; 10(4):266-85. PubMed ID: 7181672
[TBL] [Abstract][Full Text] [Related]
5. Effect of nicomol on high density lipoprotein (HDL) subfractions, HDL2e and HDL3e, separated by electrophoresis.
Ikeda S; Nagashima H; Taketa K; Watanabe M
Acta Med Okayama; 1981 Apr; 35(2):143-8. PubMed ID: 6456646
[TBL] [Abstract][Full Text] [Related]
6. [HDL cholesterol as a risk factor for arteriosclerosis (author's transl)].
Planas E; Fiol C; Sabaté I
Med Clin (Barc); 1980 Nov; 75(8):331-3. PubMed ID: 7442333
[TBL] [Abstract][Full Text] [Related]
7. Role and metabolism of high density lipoprotein subfractions--analysis of serum HDL2-cholesterol and HDL3-cholesterol in patients with various diseases by high performance liquid chromatography.
Tanaka A
Bull Tokyo Med Dent Univ; 1982 Dec; 29(4):131-7. PubMed ID: 6959738
[TBL] [Abstract][Full Text] [Related]
8. [Studies on HDL-cholesterol level in various liver diseases (author' transl)].
Okamoto Y; Matsuoka Y; Kubota C; Umegaki K; Tsujii T
Rinsho Byori; 1981 Nov; 29(11):1090-4. PubMed ID: 7334662
[No Abstract] [Full Text] [Related]
9. Effectiveness of low-dose crystalline nicotinic acid in men with low high-density lipoprotein cholesterol levels.
Martin-Jadraque R; Tato F; Mostaza JM; Vega GL; Grundy SM
Arch Intern Med; 1996 May; 156(10):1081-8. PubMed ID: 8638995
[TBL] [Abstract][Full Text] [Related]
10. ["Atherosclerosis-index" (LDL/HDL): risk indicator in lipid metabolism disorders].
Mertz DP
Med Klin; 1980 Feb; 75(4):159-61. PubMed ID: 7374617
[TBL] [Abstract][Full Text] [Related]
11. [Serum lipoprotein fractions in chronic liver diseases with and without alcoholism].
Rini GB; Averna MR; Montalto G; Di Fede G; Notarbartolo A
Boll Soc Ital Biol Sper; 1981 Aug; 57(16):1692-7. PubMed ID: 7306412
[TBL] [Abstract][Full Text] [Related]
12. [Changes in plasma lipids and lipoproteins in chronic liver diseases].
Cavanna A; Tappero R; Brizio T; Griffa G; Garlanda PF; Molino G
Quad Sclavo Diagn; 1981 Dec; 17(4):553-6. PubMed ID: 7347833
[TBL] [Abstract][Full Text] [Related]
13. [Use of nicotinic acid for correction of hypoalphacholesterolemia in patients with arteriosclerosis].
Danilenko MV; Ivaniv IuA
Kardiologiia; 1984 Feb; 24(2):110-1. PubMed ID: 6716765
[No Abstract] [Full Text] [Related]
14. [Rapid effect of glucuronyl glucosamine glycan sulfate on the blood levels of HDL-cholesterol in vascular diseases].
Ferlito S; La Spina E; Cultrera E; Puleo F; Carrà G
Arch Sci Med (Torino); 1982; 139(2):175-81. PubMed ID: 7138283
[TBL] [Abstract][Full Text] [Related]
15. [Variation in high density lipoprotein cholesterol during treatment of thyroid gland diseases].
Barbier R; Paffoy JC; Venard-Sassolas A; Berthezene F
Diabete Metab; 1980 Sep; 6(3):213-7. PubMed ID: 7439494
[TBL] [Abstract][Full Text] [Related]
16. [High density lipoproteins: the status quo (author's transl)].
Kostner GM
Wien Klin Wochenschr; 1980 Oct; 92(19):665-72. PubMed ID: 7467341
[TBL] [Abstract][Full Text] [Related]
17. Low-dose effect of simvastatin (MK-733) on serum lipids, lipoproteins, and apolipoproteins in patients with hypercholesterolemia.
Saku K; Sasaki J; Arakawa K
Clin Ther; 1989; 11(2):247-57. PubMed ID: 2736571
[TBL] [Abstract][Full Text] [Related]
18. [Hypoalphalipoproteinemia and atherosclerosis. Genetic and biochemical profile of 10 families].
Ahumada Ayala M; Jiménez Villanueva C; Cardoso Saldaña G; Sienra Pérez JC; Zamora González J; Posadas Romero C
Arch Inst Cardiol Mex; 1989; 59(1):9-18. PubMed ID: 2486742
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of the cardiovascular risk associated with atherosclerosis: HDL-cholesterol or apoproteins? (author's transl)].
Haïat R; Bugugnani MJ
Nouv Presse Med; 1982 Apr; 11(19):1487-9. PubMed ID: 6804931
[TBL] [Abstract][Full Text] [Related]
20. Aminophenyl ether compound (YM-95831), a new hypolipidemic agent with a high density lipoprotein elevating activity in rats.
Ohata I; Sakamoto N; Nitatori R; Maeno H
Arzneimittelforschung; 1983; 33(2):237-41. PubMed ID: 6682662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
